As of 2024-12-13, the Relative Valuation of Selecta Biosciences Inc (SELB) is (1.70) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.88 USD, the upside of Selecta Biosciences Inc based on Relative Valuation is -292.5%.
The range of the Relative Valuation is (3.79) - 0.49 USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.6x - 17.3x | 17.0x |
| Forward P/E multiples | 18.5x - 19.4x | 19.0x |
| Fair Price | (3.79) - 0.49 | (1.70) |
| Upside | -530.3% - -44.2% | -292.5% |
| Date | P/E |